All stock lists
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
Healthcare · Biotechnology
$3.99+$0.03 (+0.76%)
Insider Score
––Not scored
AVIR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AVIR Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue Growth (YoY) | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | $6.92 M | $6.95 M | $6.87 M | $7.12 M | $7.22 M |
| R&D Expense | $27.09 M | $28.15 M | $41.13 M | $47.82 M | $38.35 M |
| Operating Expenses | $34.01 M | $35.10 M | $48.01 M | $54.93 M | $45.57 M |
| Operating Income | -$34.01 M | -$35.10 M | -$48.01 M | -$54.93 M | -$45.57 M |
| Pretax Income | -$32.12 M | -$32.91 M | -$45.39 M | -$51.63 M | -$41.85 M |
| Tax Provision | $38.00 K | $24.00 K | $50.00 K | -$6.77 M | $196.00 K |
| Net Income | -$32.16 M | -$32.93 M | -$45.44 M | -$44.87 M | -$42.05 M |
| EPS (Basic) | -$0.40 | -$0.41 | -$0.57 | -$0.57 | -$0.53 |
| EPS (Diluted) | -$0.40 | -$0.41 | -$0.57 | -$0.57 | -$0.53 |
| Shares Outstanding | 80.22 M | 80.05 M | 79.20 M | 78.13 M | 79.05 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
